Publication Name	World Journal of Gastroenterology
Manuscript ID	1332
Country	Sweden

Received	2012-12-03 18:54
Peer-Review Started	2012-12-04 15:59
First Decision by Editorial Office Director
Return for Revision	2013-01-10 11:15
Revised	2013-02-14 20:37
Publication Fee Transferred
Second Decision by Editor	2013-04-28 14:28
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-04-29 01:02
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-05-24 19:33
Publish the Manuscript Online	2013-06-04 12:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Autobiography
Article Title	Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer
Manuscript Source	Invited Manuscript
All Author List	Torbjörn Swartling, Peter Kälebo, Kristoffer Derwinger, Bengt Gustavsson and Göran Kurlberg
Funding Agency and Grant Number	Funding Agency Grant Number Gothenburg Medical Association Lions Cancerfond Väst Björnsson Foundation
Corresponding Author	Torbjörn Swartling, MD, Sahlgrenska Academy, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital/Östra, 41685 Göteborg, Sweden. torbjorn.swartling@blixtmail.se
Key Words	Rectal cancer; Magnetic resonance imaging; Endosonography; Predictive value of tests; Neoadjuvant treatment
Core Tip	To the best of our knowledge, the possibility of increasing the accuracy of the staging of rectal cancer by combining the strengths of magnetic resonance imaging (MRI) and endosonography (ERUS) in the same patient has not been reported. In neoadjuvantly treated rectal cancer, a combination of lymph node assessment by MRI and assessment of perirectal tissue penetration by ERUS improved the staging accuracy, with stage Ⅱ as the cut-off. Furthermore, this study showed that ERUS could replace MRI in the measurement of the transaxial area of all non-stenotic tumours and in the measurement of the length of non-stenotic tumours up to 50 mm.
Publish Date	2013-06-04 12:34
Citation	Swartling T, Kälebo P, Derwinger K, Gustavsson B, Kurlberg G. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer. World J Gastroenterol 2013; 19(21): 3263-3271
URL	http://www.wjgnet.com/1007-9327/full/v19/i21/3263.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i21.3263

Full Article (PDF)	WJG-19-3263.pdf
Manuscript File	1332-Review.doc
Answering Reviewers	1332-Answering reviewers.doc
Copyright License Agreement	1332-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	1332-Language certificate.pdf
Peer-review Report	1332-Peer review(s).pdf
Scientific Editor Work List	1332-Scientific editor work list.doc